Tackling Type 2 in COPD — ASO

By Med Learning Group on AppTrack Ninja.

Chronic obstructive pulmonary disease (COPD) is a debilitating condition that is a leading global cause of hospitalization and mortality. Type 2 inflammation is a key driver of the etiopathogenesis of COPD and involves several effector immune cells, proteins, and pathways that result in life altering symptoms such as chest tightness, fatigue, chronic coughing, wheezing, difficulty breathing, and increased mucous production that can significantly impact the ability to do daily activities. Biologic therapies that target type 2 inflammation have emerged as a clinically relevant and effective tre…

Categories: Education, Medical

Keyword visibility, ranked search terms and daily position movement for Tackling Type 2 in COPD.